Insider Selling: Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Sells $110,115.98 in Stock

Ryan Specialty Holdings, Inc. (NYSE:RYANGet Free Report) Director Nicholas Dominic Cortezi sold 1,703 shares of the company’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $64.66, for a total transaction of $110,115.98. Following the transaction, the director now owns 3,800 shares in the company, valued at approximately $245,708. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Nicholas Dominic Cortezi also recently made the following trade(s):

  • On Monday, August 26th, Nicholas Dominic Cortezi sold 2,325 shares of Ryan Specialty stock. The shares were sold at an average price of $64.60, for a total transaction of $150,195.00.
  • On Wednesday, August 21st, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.15, for a total transaction of $2,280,250.00.
  • On Monday, August 19th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $64.69, for a total value of $2,264,150.00.
  • On Thursday, August 15th, Nicholas Dominic Cortezi sold 1,500 shares of Ryan Specialty stock. The stock was sold at an average price of $65.02, for a total value of $97,530.00.

Ryan Specialty Trading Up 0.2 %

Shares of RYAN stock opened at $64.56 on Friday. The stock’s 50 day simple moving average is $61.11 and its two-hundred day simple moving average is $55.41. Ryan Specialty Holdings, Inc. has a 1 year low of $41.49 and a 1 year high of $69.03. The company has a market cap of $16.81 billion, a PE ratio of 121.81, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. The company has a debt-to-equity ratio of 1.81, a current ratio of 1.09 and a quick ratio of 1.09.

Ryan Specialty (NYSE:RYANGet Free Report) last posted its quarterly earnings data on Thursday, August 1st. The company reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.56 by $0.02. Ryan Specialty had a net margin of 10.21% and a return on equity of 48.08%. The business had revenue of $695.40 million for the quarter, compared to analysts’ expectations of $695.56 million. During the same quarter in the previous year, the business posted $0.45 earnings per share. The business’s revenue was up 18.9% compared to the same quarter last year. Research analysts predict that Ryan Specialty Holdings, Inc. will post 1.81 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, August 27th. Investors of record on Tuesday, August 13th were issued a dividend of $0.11 per share. The ex-dividend date was Tuesday, August 13th. This represents a $0.44 annualized dividend and a yield of 0.68%. Ryan Specialty’s payout ratio is 83.02%.

Institutional Trading of Ryan Specialty

Several institutional investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its stake in shares of Ryan Specialty by 96.4% during the second quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock valued at $35,000 after buying an additional 297 shares during the last quarter. Crewe Advisors LLC purchased a new stake in Ryan Specialty in the 2nd quarter valued at about $39,000. Intelligent Financial Strategies purchased a new position in shares of Ryan Specialty during the first quarter worth approximately $44,000. Benjamin F. Edwards & Company Inc. bought a new stake in shares of Ryan Specialty during the first quarter valued at approximately $45,000. Finally, Rothschild Investment LLC purchased a new stake in shares of Ryan Specialty in the 2nd quarter worth $87,000. Institutional investors own 84.82% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. JPMorgan Chase & Co. raised their target price on Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a research report on Friday, August 2nd. Bank of America initiated coverage on Ryan Specialty in a research report on Wednesday, May 22nd. They set a “buy” rating and a $67.00 target price on the stock. Citigroup upped their price target on Ryan Specialty from $56.00 to $62.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 23rd. UBS Group lifted their price objective on Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a research report on Tuesday, August 13th. Finally, Keefe, Bruyette & Woods reaffirmed an “outperform” rating and issued a $62.00 target price on shares of Ryan Specialty in a report on Tuesday, July 2nd. One research analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $62.00.

View Our Latest Research Report on Ryan Specialty

Ryan Specialty Company Profile

(Get Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Insider Buying and Selling by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.